University of Colorado, Denver: Down Syndrome trials
The registry lists 12 Down Syndrome studies with University of Colorado, Denver as lead sponsor. 5 are open to participants now and 2 have results posted.
Phase 2 4Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1RecruitingNCT07598643Phase 2
- Exploring Sympathetic Nervous System Function in Individuals With Down SyndromeRecruitingNCT07238465Phase 3
- Pulmonary Health in Children With Down SyndromeRecruitingNCT04398862
- The Human Trisome ProjectRecruitingNCT02864108
- DS-Connect®: The Down Syndrome RegistryRecruitingNCT01950624
- Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
- Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down SyndromeCompletedNCT01112683Phase 4Results posted
- Therapies for Down Syndrome Regression DisorderCompletedNCT05662228Phase 2
- Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down SyndromeWithdrawnNCT05482334Phase 2
- Evaluation of Ocular Lens Proteins in Cataract From Individuals With Down SyndromeTerminatedNCT03778528
- Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping StudyTerminatedNCT02612376
- Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down SyndromeCompletedNCT02421276Not applicable